Morfometria nuclear como técnica complementar na graduação citológica do carcinoma de mama
Conteúdo do artigo principal
Resumo
Detalhes do artigo
Referências
Meijer GA, Beliën JA, van Diest PJ, Baak JP. Origins of image analysis in clinical pathology. J Clin Pathol. 1997;50(5):365-70.
http://dx.doi.org/10.1136/jcp.50.5.365
Abdalla F, Boder J, Buhmeida A, Hashmi H, Elzagheid A, Collan Y. Nuclear morphometry in FNABs of breast disease in Libyans. Anticancer Res. 2008;28(6B):3985-9.
Jalava P, Kronqvist P, Smrzova B, Juntti-Patinen L, Kuopio T, Collan YU. Nuclear volume and breast cancer prognosis. Anticancer Res. 2001;21(1B):727-32.
Kazanowska B, Jelen M, Reich A, Tarnawski W, Chybicka A. The role of nuclear morphometry in prediction of prognosis for rhabdomyosarcoma in children. Histopathology. 2004;45(4):352-9. http://dx.doi.org/10.1111/j.1365-2559.2004.01948.x
Millot C, Dufer J. Clinical applications of cytometry to human tumor analysis. Histol Histopathol. 2000;15(4):1185-200.
Milord RA, Lecell K, Epstein JI. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ. Hum Pathol. 2001;32(9):997-1002. http://dx.doi.org/10.1053/hupa.2001.27109
Lipponen P, Aaltomaa S, Papinaho S, Syrjänen K. Nucleolar organizer regions in myofibroblasts in breast cancer. Relation to cancer cell morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis. Pathol Res Pract. 1993;189(9):1030-5. http://dx.doi.org/10.1016/S0344-0338(11)80676-X
Zajdela A, De Lariva LS, Ghossein NA. The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration. Acta Cytol. 1979;23(1):75-80.
Bandlish U, Kapoor K, Shukla S. Efficacy of a modified ultrafast Papanicolaou (UFP) stain for breast aspirates. J Indian Med Assoc. 2004;102(6):309;312;326.
Hunt CM, Ellis IO, Elston CW, Locker A, Pearson D, Blamey RW. Cytological grading of breast carcinoma--a feasible proposition? Cytopathology. 1990;1(5):287-95. http://dx.doi.org/10.1111/j.1365-2303.1990.tb00362.x
Sneige N. Nuclear grading in fine needle aspirates of the breast. Cytopathol Annu. 1992;15(2):161-71.
Chieco P, Derenzini M. The Feulgen reaction 75 years on. Histochem Cell Biol. 1999;111(5):345-58. http://dx.doi.org/10.1007/s004180050367
Yildirim-Assaf S, Coumbos A, Hopfenmüller W, Foss HD, Stein H, Kühn W. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. J Clin Pathol. 2007;60(6):649-55. http://dx.doi.org/10.1136/jcp.2005.035550
Kiernan JA. Histological & histochemical methods: theory and practice. New York: Oxford Univesity Press: 2001; p. 502.
Pearse AGE. Histochemistry: theoretical and applied. Boston: Little, Brown & Company; 1986.
Papanicolau GN. A new procedure for staining vaginal smears. Science. 1942;95(2469):438-9. http://dx.doi.org/10.1126/science.95.2469.438
Davey DD, Banks ER, Jennings D, Powell DE. Comparison of nuclear grade and DNA cytometry in breast carcinoma aspirates to histologic grade in excised cancers. Am J Clin Pathol. 1993;99(6):708-13.
Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Mamografia: da prática ao controle. Ministério da Saúde. Instituto Nacional de Câncer. Rio de Janeiro: INCA 2007; p. 109-1.
Martin HE, Ellis EB. Biopsy by needle puncture and aspiration. Ann Surg. 1930;92(2):169-81. http://dx.doi.org/10.1097/00000658-193008000-00002
Howell LP, Gandour-Edwards R, O'Sullivan D. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast. Am J Clin Pathol. 1994;101(3):262-5.
Robinson IA, McKee G, Nicholson A, D'Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 1994;343(8903):947-9. http://dx.doi.org/10.1016/S0140-6736(94)90066-3
Feoli F, Paesmans M, Van Eeckhout P. Fine needle aspiration cytology of the breast: impact of experience on accuracy, using standardized cytologic criteria. Acta Cytol. 2008;52(2):145-51. http://dx.doi.org/10.1159/000325472
Elzagheid A, Kuopio T, Collan Y. Implementation of DNA cytometric measurements in fine-needle aspiration biopsy diagnostics of breast disease. Cancer. 2004;102(6):380-8. http://dx.doi.org/10.1002/cncr.20641
Remmerbach TW, Hemprich A, Böcking A. Minimally invasive brush-biopsy: innovative method for early diagnosis of oral squamous cell carcinoma. Schweiz Monatsschr Zahnmed. 2007;117(9):926-40.
Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry. Cancer Epidemiol Biomarkers Prev. 2008;17(1):102-10. http://dx.doi.org/10.1158/1055-9965.EPI-07-0175
Pektas ZO, Keskin A, Günhan O, Karslioğlu Y. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements. J Oral Maxillofac Surg. 2006;64(4):628-35. http://dx.doi.org/10.1016/j.joms.2005.12.010
Dantas K, Santos GC, Giannotto Filho O. Sistemas de graduação para carcinoma de mama: estudo comparativo da concordância cito-histológica. Rev Bras Ginecol Obstet. 2003;25(2):87-94. http://dx.doi.org/10.1590/S0100-72032003000200003
Martin HE, Ellis EB. Biopsy by needle puncture and aspiration. Ann Surg. 1930;92(2):169-81. http://dx.doi.org/10.1097/00000658-193008000-00002
Sarker S, Spigelman A, Walker M, Coleman D. Nuclear DNA content of fine needle aspirates of invasive ductal carcinomas of the breast. Anal Cell Pathol. 1997;13(1):1-8.
Andrea CE, Bleggi-Torres LF, Alves MTS. Análise da morfometria nuclear: descrição da metodologia e o papel dos softwares de edição de imagem. J Bras Patol Med Lab. 2008;44(1):51-7. http://dx.doi.org/10.1590/S1676-24442008000100010
Hoque A, Lippman SM, Boiko IV, Atkinson EN, Sneige N, Sahin A, et al. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2001;10(3):249-59.
Mommers EC, Page DL, Dupont WD, Schuyler P, Leonhart AM, Baak JP, et al. Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast. Int J Cancer. 2001;95(5):282-5. http://dx.doi.org/10.1002/1097-0215(20010920)95:5<282::AID-IJC1048>3.0.CO;2-X
Poulin N, Frost A, Carraro A, Mommers E, Guillaud M, Van Diest PJ, et al. Risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry. Anal Cell Pathol. 2003;25(3):129-38.